glp-1 agonists in development agonist pharmacology Trends the of Receptor GLP-1 receptor agonists (GLP-1RAs): cardiovascular – The GLP-1 Receptor agonists currently

Combining orthology-based classification with hierarchical functional annotation and pathway context improves the robustness of biological insights from high-throughput data

Local tumor recurrence and cancer progression occurred at a rate of 57.1% and 61.9%, respectively, in the control group, with corresponding rates of 4.5% and 9.1% in the FWGE group

Mediation analyses revealed that 147 and 186 % of the excess NAFLD risk associated with l-carnitine and DMG, respectively, was mediated by TMAO (the P values for the mediating effects were 0021 and 0036, respectively)

Novo Nordisk expects to launch the Wegovy pill in the US in early January 2026

(Lausanne) 13, 922304